TP53 and lung adenocarcinoma: To our knowledge, the TP53 c.1010G>A variant has not been described in other studies assessing somatic TP53 variants in sporadic lung adenocarcinoma (LUAD) patients (Greenman et al., 2007; Ding et al., 2008; Hammerman et al., 2012; Imielinski et al., 2012; Peifer et al., 2012; Rizvi et al., 2015; Jordan et al., 2017).